Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week. Topics include all stories related to lung cancer as well as personal stories and events.
Week ending July 27, 2014
“LSU Health Sciences Center says people with a common, hard-to-treat kind of lung cancer can join a new national trial to test drugs faster.”
“I was diagnosed with lung cancer in 2006. For the past eight years since my operation I’ve gone every few months for a blood test or scan. I just had another clear scan, and by now I’m used to the routine, although sometimes if I have a cold or I’m not feeling 100 percent I still feel as I did when I wrote the piece below, when I lived alone and feared the worst.”
Pittsburgh – “Butler Health System has begun offering lung screenings to detect health problems in smokers.”
“One-third (30%) of chemotherapy-naïve non–small cell lung cancer (NSCLC) patients treated with nivolumab, an anti-PD-1 immune checkpoint antibody, responded to treatment in a phase I study presented at the 2014 ASCO Annual Meeting. Thirty-six percent of nonsquamous patients (four) and 22% of squamous patients (two) responded to the therapy. Of the twenty patients on the trial, two patients—one nonsquamous and one squamous—had a complete response.”
“Helen Reutlinger was a heavy smoker with a history of smoking-related deaths in her family. So when she came across an ad in the paper for lung cancer screenings, and met all the requirements for the exam, she saved up her money and made an appointment.”
“A team of researchers may have found a promising new route to fighting one of the world’s deadliest cancers. They have discovered a gene that plays a role in metastasis or cancer spread of a common lung cancer. The gene helps cancer cells pull up their anchors in the primary tumor and move easily to new sites where they form new tumors.”